Followers | 21 |
Posts | 1119 |
Boards Moderated | 0 |
Alias Born | 09/25/2013 |
Thursday, June 06, 2024 9:53:01 AM
Kent Wilson, Alpine 4 CEO, had this to say: “Our 2023 Q3 performance reflects both challenges and our steadfast commitment to innovation and quality. Despite a 7% decrease in revenue in the third quarter of 2023, our 2023 year-to-date revenues remained consistent, demonstrating resilience. Our focus on R&D in 2023, with significant investments of $3.1 million, continues to drive product development and quality improvements. While we faced non-cash impairment charges of $33 million in 2023, our gross margin held steady at 21%. Further, as we proceed with our divestment plan for non-performing subsidiaries, we expect our margins to increase in Q3 and Q4 2024. Finally, the filing of this quarterly report is the first step toward getting the Company back on track and current, and we expect subsequent filings to follow relatively quickly.”
Chris Meinerz, CFO of Alpine 4, had this to say, "During the third quarter of 2023, the Company considered the sustained decrease in the Company’s publicly quoted share price and market capitalization; adverse impacts from macroeconomic conditions such as inflationary pressures and capital markets accessibility, the war in Ukraine and the war in the Middle East; and unfavorable short-term changes in the investment and operating plans of our primary customers; and as a result of these events concluded that a triggering event occurred which required the Company to perform an interim quantitative impairment test as of September 30, 2023. This assessment involved comparing the estimated fair value of each of its reporting units to the reporting unit’s carrying value, inclusive of the goodwill balance allocated to the reporting unit. Based upon the results of the impairment test, the Company concluded that the carrying value of certain reporting units exceeded their estimated fair value, resulting in a goodwill and long-lived intangible assets impairment charge. This impairment charge will not impact the Company’s cash flow.”
Recent ALPP News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 09:27:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 09:28:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 08:01:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 09:24:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:47:20 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/16/2024 08:00:56 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 01:19:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 05:00:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 09:26:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 08:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:09:12 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 08:02:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:57:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:21:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:17:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 11:13:44 PM
- Medigus: ParaZero Ramps Up Partnership with US-Based Autonomous Drone OEM Vayu Aerospace Corporation • GlobeNewswire Inc. • 02/22/2024 12:38:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 04:35:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 08:31:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:29:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 09:46:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 10:27:14 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM